Cargando…

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract encompassing two main clinical entities, Crohn’s disease and ulcerative colitis. Accumulated evidence indicates that an aberrant immune activation caused by the interplay of genetic susceptibility and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishida, Atsushi, Nishino, Kyohei, Sakai, Keitaro, Owaki, Yuji, Noda, Yoshika, Imaeda, Hirotsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218353/ https://www.ncbi.nlm.nih.gov/pubmed/34163114 http://dx.doi.org/10.3748/wjg.v27.i23.3317

Ejemplares similares

Update on gut microbiota in gastrointestinal diseases
por: Nishida, Atsushi, et al.
Publicado: (2022)

Gurvits syndrome: a case of acute esophageal necrosis associated with diabetic ketoacidosis
por: Kitawaki, Daisuke, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Expression of Interleukin-26 is upregulated in inflammatory bowel disease
por: Fujii, Makoto, et al.
Publicado: (2017)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

Diabetes and gut microbiota
por: Xi, Yue, et al.
Publicado: (2021)

Gut microbiota in obesity
por: Liu, Bing-Nan, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
por: Mandour, Mandour Omer, et al.
Publicado: (2022)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

Management of early rectal cancer; current surgical options and future direction
por: Chavda, Vijay, et al.
Publicado: (2021)

The gut microbiota and its interactions with cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Effects of sclerostin antibody on bone healing
por: Mihara, Atsushi, et al.
Publicado: (2021)

Gut microbiota and COVID-19: An intriguing pediatric perspective
por: Valentino, Maria Sole, et al.
Publicado: (2022)

Potential role of the gut microbiota in synthetic torpor and therapeutic hypothermia
por: Sisa, Claudia, et al.
Publicado: (2017)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Gut microbiota mediated molecular events and therapy in liver diseases
por: Qi, Xiaoqiang, et al.
Publicado: (2020)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome
por: Chen, Si-Yue, et al.
Publicado: (2022)

Interaction between gut microbiota and COVID-19 and its vaccines
por: Leung, John S M
Publicado: (2022)

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis
por: Luo, Ming, et al.
Publicado: (2023)

Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future
por: Viganò, Chiara, et al.
Publicado: (2021)

Telenutrition for the management of inflammatory bowel disease: Benefits, limits, and future perspectives
por: Güney Coşkun, Merve, et al.
Publicado: (2023)

From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota
por: Bauer, Eugen, et al.
Publicado: (2018)

Gut microbiota in common elderly diseases affecting activities of daily living
por: Shimizu, Yukihiro
Publicado: (2018)

Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
por: Yang, Jiayue, et al.
Publicado: (2020)

Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity
por: Wei, Yan-Xia, et al.
Publicado: (2021)

The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
por: Kim, Jaeho, et al.
Publicado: (2021)

Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023)

Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges
por: Choden, Tenzin, et al.
Publicado: (2018)

Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions
por: Gubatan, John, et al.
Publicado: (2021)

Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm
por: Martens, Eric C., et al.
Publicado: (2009)

Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review
por: Koutouratsas, Tilemachos, et al.
Publicado: (2021)

Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation
por: Xiao, Shuiming, et al.
Publicado: (2014)

Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus
por: Kant, Ravi, et al.
Publicado: (2022)

Functional gastrointestinal disorders and gut-brain axis: What does the future hold?
por: Mukhtar, Kashif, et al.
Publicado: (2019)

Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
por: Wei, Shaodong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6np2d2dkh96tdjgk6nt3n9mbp2